Histamine release from human leukocytes: modulation by a cytochalasin B-sensitive barrier
AUTOR(ES)
Colten, Harvey R.
RESUMO
Cytochalasin B, a metabolic product of several fungi, enhances up to 10-fold the sensitivity and reactivity of human leukocytes to antigen E or anti-IgE-mediated histamine release. The effect of cytochalasin B is a result of its action on the second, antigen-independent, stage of histamine release. These data suggest that normally, antigen-triggered histamine release is modulated by a cytochalasin-sensitive barrier (CSB). This CSB modulation of histamine release can be separated from the modulating effect of cyclic adenosine monophosphate (AMP).
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=292344Documentos Relacionados
- Histamine release from human leukocytes: studies with deuterium oxide, colchicine, and cytochalasin B
- Ultraviolet B-Sensitive Rice Cultivar Deficient in Cyclobutyl Pyrimidine Dimer Repair.
- Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.
- Cytochalasin B: Effect on Lysosomal Enzyme Release from Human Leukocytes
- Histamine release from human leukocytes when stimulated by Mycoplasma salivarium.
